Nagoya City, Japan

Nagoya, Aichi-ken 466-8560

0 studies enrolling now · 1 studies all time

What they study most

Diabetic Macular Edema (DME)

Studies at this site

• A Study of 2 Doses of EYE103 Compared With Ranibizumab (0.5 mg) in Participants With DME — Running, not enrolling